Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms
Open Access
- 20 May 2022
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 30 (7) , 2401-2415
Abstract
No abstract availableKeywords
Funding Information
- Hessisches Ministerium für Wissenschaft und Kunst (III L 5-519/03/03.001-(0015 ))
- Deutsche Krebshilfe (70114099)
This publication has 110 references indexed in Scilit:
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and TherapyAnnual Review of Pharmacology and Toxicology, 2015
- LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virusProceedings of the National Academy of Sciences, 2013
- Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of InfectivityMolecular Therapy Nucleic Acids, 2012
- The immunomodulatory properties of the CD5 lymphocyte receptor in health and diseaseCurrent Opinion in Immunology, 2011
- Structural changes of envelope proteins during alphavirus fusionNature, 2010
- Targeted Transduction via CD4 by a Lentiviral Vector Uses a Clathrin-Mediated Entry PathwayJournal of Virology, 2009
- Cell Type-Specific Targeting with Surface-Engineered Lentiviral Vectors Co-displaying OKT3 Antibody and Fusogenic MoleculePharmaceutical Research, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- Rescue and propagation of fully retargeted oncolytic measles virusesNature Biotechnology, 2005
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003